Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Report

China Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Market Research Report 2023-2029

  • POSTDATE：Aug 25, 2023
  • PAGES：151
  • REPORT CODE：GMM1754917
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Androgen Deprivation Therapy (ADT) and GnRH Agonists industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis International AG

    • Pfizer Inc

    • Endo Pharmaceuticals Inc

    • Sanofi SA

    • Bayer AG

    • GlaxoSmithKline plc

    • Veru Inc

    • Orion Corporation

    • Astellas Pharma Inc

    • Ferring BV

    By Type:

    • GnRH Agonists

    • Androgen Deprivation Therapy (ADT)

    By Application:

    • Hospital pharmacies

    • Online pharmacies

    • Retail pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Overview 2018-2029

    • 1.1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Development Overview

    • 1.2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Development History

    • 1.3 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Market Size (2018-2029)

    • 1.4 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis by Type from Production Side

      • 1.4.1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume, Production Value and Growth Rate of GnRH Agonists (2018-2029)

      • 1.4.2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume, Production Value and Growth Rate of Androgen Deprivation Therapy (ADT) (2018-2029)

    • 1.5 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis by Application from Consumption End

      • 1.5.1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume, Sales Value and Growth Rate of Hospital pharmacies (2018-2029)

      • 1.5.2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume, Sales Value and Growth Rate of Online pharmacies (2018-2029)

      • 1.5.3 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume, Sales Value and Growth Rate of Retail pharmacies (2018-2029)

    • 1.6 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis by Region

      • 1.6.1 North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    Chapter 2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Status and Competition Analysis in 2023

      • 2.2.3 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Development

    Chapter 3 Androgen Deprivation Therapy (ADT) and GnRH AgonistsIndustry Chain Analysis

    • 3.1 Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Chain

    • 3.2 Androgen Deprivation Therapy (ADT) and GnRH Agonists Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Androgen Deprivation Therapy (ADT) and GnRH Agonists Market

    • 3.3 Androgen Deprivation Therapy (ADT) and GnRH Agonists Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Androgen Deprivation Therapy (ADT) and GnRH Agonists Market

    Chapter 4 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 4.1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Total Production Volume and Growth Rate from Production Side

    • 4.5 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume and Growth Rate, by Type

      • 4.5.1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume and Growth Rate of GnRH Agonists

      • 4.5.2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume and Growth Rate of Androgen Deprivation Therapy (ADT)

    Chapter 5 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Total Market Size and Growth Rate from Consumption End

    • 5.5 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate, by Application

      • 5.5.1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate of Hospital pharmacies

      • 5.5.2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate of Online pharmacies

      • 5.5.3 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate of Retail pharmacies

    Chapter 6 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Region

    • 6.1 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume and Production Value, by Region

    • 6.2 China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume and Sales Value, by Region

    Chapter 7 North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis

    • 7.1 North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 7.2 North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    Chapter 8 Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis

    • 8.1 Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 8.2 Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    Chapter 9 South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis

    • 9.1 South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 9.2 South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    Chapter 10 East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis

    • 10.1 East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 10.2 East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    Chapter 11 Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis

    • 11.1 Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 11.2 Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    Chapter 12 Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis

    • 12.1 Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 12.2 Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    Chapter 13 Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Analysis

    • 13.1 Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Type

    • 13.2 Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis International AG

        • 14.1.1 Novartis International AG Company Profile

        • 14.1.2 Novartis International AG Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer Inc

        • 14.2.1 Pfizer Inc Company Profile

        • 14.2.2 Pfizer Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Endo Pharmaceuticals Inc

        • 14.3.1 Endo Pharmaceuticals Inc Company Profile

        • 14.3.2 Endo Pharmaceuticals Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sanofi SA

        • 14.4.1 Sanofi SA Company Profile

        • 14.4.2 Sanofi SA Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bayer AG

        • 14.5.1 Bayer AG Company Profile

        • 14.5.2 Bayer AG Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GlaxoSmithKline plc

        • 14.6.1 GlaxoSmithKline plc Company Profile

        • 14.6.2 GlaxoSmithKline plc Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Veru Inc

        • 14.7.1 Veru Inc Company Profile

        • 14.7.2 Veru Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Orion Corporation

        • 14.8.1 Orion Corporation Company Profile

        • 14.8.2 Orion Corporation Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Astellas Pharma Inc

        • 14.9.1 Astellas Pharma Inc Company Profile

        • 14.9.2 Astellas Pharma Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Ferring BV

        • 14.10.1 Ferring BV Company Profile

        • 14.10.2 Ferring BV Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Research Conclusions

    • 15.2 Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Market Size (2018-2029)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume, Production Value and Growth Rate of GnRH Agonists (2018-2029)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume, Production Value and Growth Rate of Androgen Deprivation Therapy (ADT) (2018-2029)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume, Sales Value and Growth Rate of Hospital pharmacies (2018-2029)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume, Sales Value and Growth Rate of Online pharmacies (2018-2029)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume, Sales Value and Growth Rate of Retail pharmacies (2018-2029)

    • Figure North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    • Figure Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    • Figure South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    • Figure East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate from 2018-2029

    • Figure Androgen Deprivation Therapy (ADT) and GnRH Agonists Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Share by Type in 2018

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Share by Type in 2023

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume and Growth Rate of GnRH Agonists (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume and Growth Rate of Androgen Deprivation Therapy (ADT) (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Share by Application in 2018

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Share by Application in 2023

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Total Market Size and Growth Rate from Consumption End

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate of Hospital pharmacies (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate of Online pharmacies (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Market Size and Growth Rate of Retail pharmacies (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Region (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Region (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Region (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Value by Region (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Value Share by Region (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Value Share by Region (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Region (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Region (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Region (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Value by Region (2018-2023)

    • Table China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Value Share by Region (2018-2023)

    • Figure China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Value Share by Region (2018-2023)

    • Table North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Type (2018-2023)

    • Table North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Figure North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Table North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Application (2018-2023)

    • Table North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Figure North China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Table Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Type (2018-2023)

    • Table Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Figure Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Table Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Application (2018-2023)

    • Table Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Figure Central China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Table South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Type (2018-2023)

    • Table South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Figure South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Table South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Application (2018-2023)

    • Table South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Figure South China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Table East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Type (2018-2023)

    • Table East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Figure East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Table East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Application (2018-2023)

    • Table East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Figure East China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Table Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Type (2018-2023)

    • Table Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Figure Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Table Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Application (2018-2023)

    • Table Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Table Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Type (2018-2023)

    • Table Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Figure Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Table Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Application (2018-2023)

    • Table Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Table Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume by Type (2018-2023)

    • Table Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Figure Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Production Volume Share by Type (2018-2023)

    • Table Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume by Application (2018-2023)

    • Table Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Androgen Deprivation Therapy (ADT) and GnRH Agonists Sales Volume Share by Application (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Endo Pharmaceuticals Inc Company Profile

    • Table Endo Pharmaceuticals Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Veru Inc Company Profile

    • Table Veru Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Orion Corporation Company Profile

    • Table Orion Corporation Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Inc Company Profile

    • Table Astellas Pharma Inc Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)

    • Table Ferring BV Company Profile

    • Table Ferring BV Androgen Deprivation Therapy (ADT) and GnRH Agonists Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US